Clinical Connection Home
  Welcome To
Clinical Connection
 

Trials
Alerts

Trials
Search

Health
Forum

Health
News

RSS

Intro

Clinics &
Sponsors

Member
Login
View Clinical Trial (Medical Research Study)

A Study to Evaluate the Efficacy of Xolair in Atopic Asthmatics - NCT00096954-53228 (Clinical Trial 122583)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy122583.aspx



** Please review additional "Nearby Studies" on right ----->

Clinical Trials Notification
Clinical Trials Search

City:  Greenfield
State:  
WI
Zip Code: 53228
Conditions: Asthma
Purpose: This is a multicenter, parallel-group, double-blind, randomized, placebo-controlled study that will enroll approximately 300 subjects. These subjects will be 12-75 years old with atopic asthma, have a history of asthma exacerbations, have elevated serum total IgE, have a baseline FEV1 ≥ 80% predicted, and be on inhaled corticosteroids with or without other controller asthma medications (e.g., long-acting β2-agonists [LABAs], leukotriene receptor antagonist [LTRA], or immunotherapy).
Study summary:
Criteria: Inclusion Criteria: - Have a documented history of asthma as well as evidence of ≥ 12% reversibility of FEV1. Evidence of ≥ 12% reversibility of FEV1 may be obtained by any one of the following measures: 1) Documentation of ≥ 12% reversibility of FEV1 after albuterol administration at any time during the preceding 24 months; 2) Documentation of ≥ 12% improvement in FEV1 with two separate measurements obtained within a 4-week period surrounding an asthma exacerbation during the preceding 24 months; 3) Demonstration of ≥ 12%reversibility of FEV1 after albuterol administration at the time of screening - Have baseline FEV1 ≥ 80% predicted normal value prior to randomization - Have a positive skin test (diameter of wheal ≥ 3 mm vs. control) or in vitro RAST(R) or ImmunoCap(R) to one relevant perennial aeroallergen such as cat or house dust mites documented within the previous year - Be receiving at least an inhaled corticosteroid dosage of fluticasone dry powder inhaler (DPI) ≥ 200 ug/day or equivalent ex-valve dose during the 12 weeks prior to the screening visit - During the 4-week run-in period prior to randomization, demonstrate evidence of inadequate asthma symptom control despite inhaled corticosteroids with or without other controller asthma medications (e.g., LABA, LTRA, immunotherapy). Inadequate asthma symptom control is defined as at least one of the following reported on the subject diary card during the 4-week run-in period: Daytime asthma symptoms as a score of ≥ 1 (scale of 0-4) on at least 20 of 28 days (missing data to be treated as a day with no symptoms) and a mean symptom score of ≥ 1.5 (mean will be calculated based on only data supplied; missing values will not be considered) or Nighttime awakening because of asthma symptoms (more than 4 times during the 4-week run-in period) - Meet the study drug-dosing table eligibility criteria (serum baseline IgE level ≥ 30 to ≤ 1300 IU/mL and body weight ≥ 20 to ≤ 150 kg) - If a female of childbearing potential, use an effective method of contraception (in the opinion of the investigator) to prevent pregnancy and agree to continue to practice an acceptable method of contraception for the duration of their participation in the study Exclusion Criteria: - Have received chronic systemic corticosteroids (oral or intravenous) within 3 months or have received a burst of oral corticosteroids within the last 2 weeks prior to screening - Have received Xolair therapy at any time within 12 months prior to screening - Are pregnant or lactating - Have a known hypersensitivity to any ingredients of Xolair, including excipients (sucrose, histidine, polysorbate 20) - Have a lifetime history of smoking > 10-pack years - Have active lung disease other than asthma (e.g., chronic bronchitis, emphysema, cystic fibrosis, chronic obstructive pulmonary disease) - Have a history of upper respiratory infection or lower respiratory infection within the 30 days prior to randomization - Have a diagnosis of aspirin or nonsteroidal anti-inflammatory drug-induced asthma - Have taken immunosuppressants or other investigational drugs within the 30 days prior to screening - Have a significant medical illness other than asthma
Study is available at: Allergy Asthma & Sinus Center
Greenfield, WI 53228
United States

Primary Contact:
Jenny Vick
Email: jenny@aasc-drsteven.com
Phone: 414-529-8519

Secondary Contact:
Trial Information Support Line
Phone: 888-662-6728
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 15, 2010
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.

 
 
 
 
 
 
 
 












Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.


Within 25 Miles

Diabetic Gastroparesis - Milwaukee WI



Within 50 Miles

Type 2 Diabetes - Kenosha WI

Gout - Kenosha WI

Osteoarthritis of the Knee - Gurnee IL

Bipolar Disorder - Libertyville IL

Childhood Depression - Libertyville IL

Attention Deficit Hyperactivity Disorder (ADHD) - Libertyville IL



Within 100 Miles

Alzheimer's Disease - Chicago IL

Healthy Female Volunteers (Pregnancy Testing) - Chicago IL

Hot Flashes - Chicago IL

Hypoactive Sexual Desire Disorder (HSDD) - Chicago IL

Hypoactive Sexual Desire Disorder - Chicago IL

Heart Disease - Chicago IL

Heart Disease - Chicago IL

Low Back Pain - Chicago IL

Type 2 Diabetes - Chicago IL

 
Home | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Message Board | Investigators
Links | Terms And Conditions | Sitemap | Suggestion/Feedback
© 1998-2009 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.